Free Trial
NASDAQ:CVRX

CVRx (CVRX) Stock Price, News & Analysis

CVRx logo
$12.90 +0.40 (+3.20%)
(As of 01:00 PM ET)

About CVRx Stock (NASDAQ:CVRX)

Key Stats

Today's Range
$12.28
$12.94
50-Day Range
$8.02
$15.83
52-Week Range
$6.40
$33.13
Volume
91,387 shs
Average Volume
268,844 shs
Market Capitalization
$313.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.67
Consensus Rating
Moderate Buy

Company Overview

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

CVRx Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
73rd Percentile Overall Score

CVRX MarketRank™: 

CVRx scored higher than 73% of companies evaluated by MarketBeat, and ranked 246th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CVRx has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on 5 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    CVRx has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about CVRx's stock forecast and price target.
  • Earnings Growth

    Earnings for CVRx are expected to grow in the coming year, from ($2.62) to ($2.13) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CVRx is -4.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CVRx is -4.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    CVRx has a P/B Ratio of 3.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    14.32% of the float of CVRx has been sold short.
  • Short Interest Ratio / Days to Cover

    CVRx has a short interest ratio ("days to cover") of 6.6.
  • Change versus previous month

    Short interest in CVRx has recently decreased by 5.34%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    CVRx does not currently pay a dividend.

  • Dividend Growth

    CVRx does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    14.32% of the float of CVRx has been sold short.
  • Short Interest Ratio / Days to Cover

    CVRx has a short interest ratio ("days to cover") of 6.6.
  • Change versus previous month

    Short interest in CVRx has recently decreased by 5.34%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    CVRx has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for CVRx this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for CVRX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CVRx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $19,419.00 in company stock.

  • Percentage Held by Insiders

    18.90% of the stock of CVRx is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    75.27% of the stock of CVRx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about CVRx's insider trading history.
Receive CVRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CVRx and its competitors with MarketBeat's FREE daily newsletter.

CVRX Stock News Headlines

Has Trump Finally Gone Too Far?
Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.
William Blair Forecasts CVRx's FY2026 Earnings (NASDAQ:CVRX)
CVRx price target raised to $22 from $17 at Canaccord
See More Headlines

CVRX Stock Analysis - Frequently Asked Questions

CVRx's stock was trading at $31.44 at the beginning of 2024. Since then, CVRX stock has decreased by 59.0% and is now trading at $12.90.
View the best growth stocks for 2024 here
.

CVRx, Inc. (NASDAQ:CVRX) announced its quarterly earnings results on Tuesday, October, 29th. The company reported ($0.57) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.45) by $0.12. The company had revenue of $13.37 million for the quarter, compared to analysts' expectations of $13.28 million. CVRx had a negative net margin of 123.75% and a negative trailing twelve-month return on equity of 89.06%.

CVRx (CVRX) raised $100 million in an initial public offering (IPO) on Wednesday, June 30th 2021. The company issued 6,250,000 shares at $15.00-$17.00 per share.

Top institutional investors of CVRx include Parkman Healthcare Partners LLC (2.81%), Emerald Advisers LLC (1.87%), Geode Capital Management LLC (1.22%) and Emerald Mutual Fund Advisers Trust (1.33%). Insiders that own company stock include & Johnson Johnson, Kirk G Nielsen, Joseph P Slattery, Kevin Hykes and Paul Verrastro.
View institutional ownership trends
.

Shares of CVRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that CVRx investors own include Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
10/29/2024
Today
12/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:CVRX
Employees
200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$16.67
High Stock Price Target
$22.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+29.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.71
Research Coverage
7 Analysts

Profitability

Net Income
$-41,200,000.00
Net Margins
-123.75%
Pretax Margin
-123.40%

Debt

Sales & Book Value

Annual Sales
$47.26 million
Book Value
$3.65 per share

Miscellaneous

Free Float
19,678,000
Market Cap
$313.01 million
Optionable
Optionable
Beta
1.20
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NASDAQ:CVRX) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners